The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
HER family protein expression and activation predicts response to combination T-DM1/pertuzumab in HER2+ patients in the I-SPY 2 TRIAL.
 
Julia Dianne Wulfkuhle
Honoraria - Dava Oncology
Patents, Royalties, Other Intellectual Property - Patents Royalties
 
Denise M. Wolf
No Relationships to Disclose
 
Christina Yau
Employment - NantWorks
 
Rosa Isela Gallagher
No Relationships to Disclose
 
Lamorna Brown Swigart
No Relationships to Disclose
 
Gillian L. Hirst
No Relationships to Disclose
 
Douglas Yee
No Relationships to Disclose
 
Paula Raffin Pohlmann
Leadership - Immunonet BioSciences
Stock and Other Ownership Interests - Immunonet BioSciences
Consulting or Advisory Role - HERON; Immunonet BioSciences; OncoPlex Diagnostics; Personalized Cancer Therapy; Pfizer; Puma Biotechnology
Speakers' Bureau - Genentech/Roche
Research Funding - Advanced Cancer Therapeutics (Inst); Caris Centers of Excellence (Inst); Caris Centers of Excellence (Inst); Cascadian Therapeutics (Inst); Fabre-Kramer (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Pfizer (Inst); Pfizer (Inst); Pieris Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - United States Patent no. 8,486,413.; United States Patent no. 8,501,417; United States Patent no. 9,023,362; United States Patent no. 9,745,377
 
Anthony D. Elias
Stock and Other Ownership Interests - Abbott Laboratories; Abbvie; Agilent; Alexion Pharmaceuticals; Align Oncology; Allergan; Amgen; Biogen; Bristol-Myers Squibb; Celgene; Cigna; Gilead Sciences; Illumina; Lilly; Merck; Pfizer; United Health Group
Consulting or Advisory Role - HSIX
Research Funding - Astellas Pharma (Inst); CytRx Corporation (Inst); Eisai (Inst); Eisai (Inst); Genentech (Inst); ImClone Systems (Inst); Incyte (Inst); Johnson & Johnson (Inst); Medivation (Inst)
 
Stacy L. Moulder
Honoraria - Novartis; Pfizer (I)
Research Funding - Bayer (Inst); EMD Serono (Inst); Genentech (Inst); Genentech (Inst); Novartis (Inst); Oncothyreon (Inst); Pfizer (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Novartis; Pfizer (I)
 
Debu Tripathy
Consulting or Advisory Role - CellMax Life; Genomic Health; GlaxoSmithKline; Nektar; Novartis; Pfizer; Polyphor; Puma Biotechnology; Sellas Life Sciences
Research Funding - Genentech/Roche (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Novartis
 
Angela DeMichele
Honoraria - Pfizer; Pfizer
Consulting or Advisory Role - Calithera Biosciences; Context Therapeutics; Novartis; Pfizer (I)
Research Funding - Bayer (Inst); Calithera Biosciences (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Millennium (Inst); Pfizer (Inst); Veridex (Inst); Wyeth (Inst)
Travel, Accommodations, Expenses - Calithera Biosciences; Novartis; Pfizer; Pfizer; Pfizer
 
Laura Esserman
Consulting or Advisory Role - Blue Cross Blue Shield Association
Research Funding - Merck
Travel, Accommodations, Expenses - Blue Cross Blue Shield Association
 
Donald A. Berry
Employment - Berry Consultants
Leadership - Berry Consultants
Stock and Other Ownership Interests - Berry Consultants
Consulting or Advisory Role - Berry Consultants
Travel, Accommodations, Expenses - Berry Consultants
 
Laura van 't Veer
Employment - Agendia
Leadership - Agendia
Stock and Other Ownership Interests - Agendia
 
Emanuel Petricoin
Leadership - Ceres Nanosciences; Perthera
Stock and Other Ownership Interests - Avant Diagnostics; Ceres Nanosciences; Perthera
Consulting or Advisory Role - Avant Diagnostics; AZGen; Ceres Nanosciences; Perthera
Research Funding - Abbvie (Inst); Ceres Nanosciences (Inst); GlaxoSmithKline (Inst); Symphony Evolution (Inst)
Patents, Royalties, Other Intellectual Property - NIH Patents Licensing Fee Distribution/Royalty; University assigned patent licensing fee/royalty
Travel, Accommodations, Expenses - Ceres Nanosciences; Perthera